STAT3 exerts pro-tumor and anti-autophagy roles in cervical cancer

Lin Wu1,2, Bowen Shen3, Junpeng Li2

  • 1The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.

Diagnostic Pathology
|January 21, 2022
PubMed
Abstract

Insights

Signal transducer and activator of transcription 3 (STAT3) may increase cervical cancer cell autophagy via the Bcl2-Beclin1 pathway. Inhibiting STAT3 could be a therapeutic strategy for cervical cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • STAT3 is implicated in cervical cancer progression.
  • STAT3 can downregulate LC3B, a key autophagy biomarker.
  • The precise role of STAT3 in cervical cancer autophagy is not fully understood.

Purpose of the Study:

  • To investigate the relationship between STAT3 and LC3B protein levels.
  • To determine if STAT3 inhibits cervical cancer cell autophagy via the Bcl2-Beclin1 axis.
  • To assess STAT3's impact on cancer cell proliferation, migration, and colony formation.

Main Methods:

  • Analysis of STAT3 and LC3B expression in cervical cancer tissues.
  • STAT3 knockout/knockdown experiments in vitro and in vivo.
  • Assessment of autophagy markers and cancer cell phenotypes.
  • Examination of Bcl2-Beclin1 complex interactions.

Main Results:

  • STAT3 was overexpressed and negatively correlated with LC3B in cervical cancer.
  • STAT3 inhibition/depletion enhanced autophagy and reduced cancer cell proliferation, migration, and tumorigenesis.
  • STAT3 positively correlated with Bcl2 and negatively with Beclin1, implicating the Bcl2-Beclin1 complex.

Conclusions:

  • STAT3 appears to upregulate cervical cancer cell autophagy through the Bcl2-Beclin1 axis.
  • STAT3 represents a potential prognostic and therapeutic target for cervical cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K